{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T08:59:47Z","timestamp":1771059587828,"version":"3.50.1"},"reference-count":92,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Porto"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Cardiomyopathies may be hereditary and associated with a familial predilection. Morbidity and mortality can be caused by heart failure, sudden death, or arrhythmias. Sometimes these events are the first manifestations of cardiovascular disease. Hypertrophic cardiomyopathy and arrhythmogenic cardiomyopathy are perhaps most thoroughly studied in that context. Dilated cardiomyopathy, although most frequently of secondary etiology, has a significant familial cluster. Noncompaction of the left ventricle can sometimes be seen in healthy individuals and, in other instances, is associated with severe LV dysfunction. Genetic testing is of utmost importance, since it might allow for the identification of individuals carrying mutations predisposing them to these diseases. In addition, certain variants may benefit from tailored therapeutic regimens, and thus searching for a causal mutation can impact clinical practice and is recommended for all patients with HCM or ACM. Patients with DCM and positive family history should be included as well. Regular follow-ups are advised, even in those with negative phenotypes, because these disorders are often age dependent. During pregnancy and in the case of athletes, special consideration should be made as well. We intend to summarize the most current evidence regarding their management.<\/jats:p>","DOI":"10.3390\/jcm12144706","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:56:47Z","timestamp":1689555407000},"page":"4706","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Recommendations for the Management of Cardiomyopathy Mutation Carriers: Evidence, Doubts, and Intentions"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8253-5685","authenticated-orcid":false,"given":"Jos\u00e9 F.","family":"Couto","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Porto, 4200-450 Porto, Portugal"}]},{"given":"Elisabete","family":"Martins","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Porto, 4200-450 Porto, Portugal"},{"name":"Centro Hospitalar Universit\u00e1rio S\u00e3o Jo\u00e3o, Member of the European Reference Network for Rare, Low-Prevalence, or Complex Diseases of the Heart (ERN GUARD-Heart), 4200-319 Porto, Portugal"},{"name":"Center for Health Technology and Services Research (CINTESIS@RISE), Faculty of Medicine, University of Porto, 4200-450 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: A position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.4070\/kcj.2021.0154","article-title":"Genetics of Cardiomyopathy: Clinical and Mechanistic Implications for Heart Failure","volume":"51","author":"Kim","year":"2021","journal-title":"Korean Circ. J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.yjmcc.2020.03.006","article-title":"A homozygous DSC2 deletion associated with arrhythmogenic cardiomyopathy is caused by uniparental isodisomy","volume":"141","author":"Brodehl","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1056\/NEJMoa075463","article-title":"Shared genetic causes of cardiac hypertrophy in children and adults","volume":"358","author":"Morita","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1136\/hrt.2007.134684","article-title":"Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes","volume":"94","author":"Kaski","year":"2008","journal-title":"Heart"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","article-title":"Hypertrophic cardiomyopathy","volume":"381","author":"Maron","year":"2013","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/01.CIR.0000066323.15244.54","article-title":"Hypertrophic cardiomyopathy: Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy","volume":"107","author":"Richard","year":"2003","journal-title":"Circulation"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1161\/01.CIR.92.4.785","article-title":"Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults","volume":"92","author":"Maron","year":"1995","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0735-1097(02)02976-5","article-title":"Relationship of race to sudden cardiac death in competitive athletes with hypertrophic cardiomyopathy","volume":"41","author":"Maron","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jacc.2005.04.043","article-title":"Gender-related differences in the clinical presentation and outcome of hypertrophic cardiomyopathy","volume":"46","author":"Olivotto","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12265-008-9025-1","article-title":"Genetic evaluation of familial cardiomyopathy","volume":"1","author":"Judge","year":"2008","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.hfc.2017.12.001","article-title":"Genetic Testing for Cardiomyopathies in Clinical Practice","volume":"14","author":"Ingles","year":"2018","journal-title":"Heart Fail. Clin."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/0971-9784.129841","article-title":"Hypertrophic cardiomyopathy: Part 1\u2014Introduction, pathology and pathophysiology","volume":"17","author":"Varma","year":"2014","journal-title":"Ann. Card. Anaesth."},{"key":"ref_16","first-page":"e558","article-title":"2020 AHA\/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehu284","article-title":"2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC)","volume":"35","author":"Elliott","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCRESAHA.117.309711","article-title":"Classification, Epidemiology, and Global Burden of Cardiomyopathies","volume":"121","author":"McKenna","year":"2017","journal-title":"Circ. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","article-title":"Dilated Cardiomyopathy: Genetic Determinants and Mechanisms","volume":"121","author":"McNally","year":"2017","journal-title":"Circ. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.CIR.0000078641.19365.4C","article-title":"Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance","volume":"108","author":"McCrohon","year":"2003","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0735-1097(01)01738-7","article-title":"A standardized definition of ischemic cardiomyopathy for use in clinical research","volume":"39","author":"Felker","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/j.jacc.2016.03.590","article-title":"The Diagnosis and Evaluation of Dilated Cardiomyopathy","volume":"67","author":"Japp","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/eurheartj\/ehs397","article-title":"Diagnostic work-up in cardiomyopathies: Bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Rapezzi","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated cardiomyopathy: The complexity of a diverse genetic architecture","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/CIRCULATIONAHA.106.646778","article-title":"Prevalence of desmin mutations in dilated cardiomyopathy","volume":"115","author":"Taylor","year":"2007","journal-title":"Circulation"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Koelemen, J., Gotthardt, M., Steinmetz, L.M., and Meder, B. (2021). RBM20-Related Cardiomyopathy: Current Understanding and Future Options. J. Clin. Med., 10.","DOI":"10.3390\/jcm10184101"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Gaertner, A., Bloebaum, J., Brodehl, A., Klauke, B., Sielemann, K., Kassner, A., Fox, H., Morshuis, M., Tiesmeier, J., and Schulz, U. (2021). The Combined Human Genotype of Truncating TTN and RBM20 Mutations Is Associated with Severe and Early Onset of Dilated Cardiomyopathy. Genes, 12.","DOI":"10.3390\/genes12060883"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: A position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0140-6736(09)60256-7","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"373","author":"Basso","year":"2009","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJMra1509267","article-title":"Arrhythmogenic Right Ventricular Cardiomyopathy","volume":"376","author":"Corrado","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198801213180301","article-title":"Right ventricular cardiomyopathy and sudden death in young people","volume":"318","author":"Thiene","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ijcard.2003.10.037","article-title":"Prevalence of right ventricular dysplasia-cardiomyopathy in a non-referral hospital","volume":"97","author":"Peters","year":"2004","journal-title":"Int. J. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/cvr\/cvac072","article-title":"Spatial transcriptomics unveils ZBTB11 as a regulator of cardiomyocyte degeneration in arrhythmogenic cardiomyopathy","volume":"119","author":"Boogerd","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.hrthm.2020.01.035","article-title":"Clinical characteristics and determinants of the phenotype in TMEM43 arrhythmogenic right ventricular cardiomyopathy type 5","volume":"17","author":"Dominguez","year":"2020","journal-title":"Heart Rhythm."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Zink, M., Seewald, A., Rohrbach, M., Brodehl, A., Liedtke, D., Williams, T., Childs, S.J., and Gerull, B. (2022). Altered Expression of TMEM43 Causes Abnormal Cardiac Structure and Function in Zebrafish. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179530"},{"key":"ref_37","first-page":"15","article-title":"Mutations in ILK, encoding integrin-linked kinase, are associated with arrhythmogenic cardiomyopathy","volume":"208","author":"Brodehl","year":"2019","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1093\/hmg\/ddq387","article-title":"De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy","volume":"19","author":"Klauke","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"ref_40","first-page":"787","article-title":"Diagnosing arrhythmogenic right ventricular cardiomyopathy by 2010 Task Force Criteria: Clinical performance and simplified practical implementation","volume":"22","author":"Bosman","year":"2020","journal-title":"EP Eur."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"5172308","DOI":"10.1155\/2016\/5172308","article-title":"The Current Approach to Diagnosis and Management of Left Ventricular Noncompaction Cardiomyopathy: Review of the Literature","volume":"2016","author":"Bennett","year":"2016","journal-title":"Cardiol. Res. Pract."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","article-title":"Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/eurheartj\/ehq508","article-title":"Left ventricular non-compaction revisited: A distinct phenotype with genetic heterogeneity?","volume":"32","author":"Oechslin","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0735-1097(00)00755-5","article-title":"Long-term follow-up of 34 adults with isolated left ventricular noncompaction: A distinct cardiomyopathy with poor prognosis","volume":"36","author":"Oechslin","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s11897-014-0227-3","article-title":"Non-compaction cardiomyopathy: Prevalence, prognosis, pathoetiology, genetics, and risk of cardioembolism","volume":"11","author":"Almeida","year":"2014","journal-title":"Curr. Heart Fail. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.cardfail.2011.05.002","article-title":"Isolated noncompaction of the left ventricular myocardium in adults: A systematic overview","volume":"17","author":"Bhatia","year":"2011","journal-title":"J. Card. Fail."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.hrthm.2011.05.020","article-title":"HRS\/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA)","volume":"8","author":"Ackerman","year":"2011","journal-title":"Heart Rhythm"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijcard.2010.02.049","article-title":"Neuromuscular and cardiac comorbidity determines survival in 140 patients with left ventricular hypertrabeculation\/noncompaction","volume":"150","author":"Blazek","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Kulikova, O., Brodehl, A., Kiseleva, A., Myasnikov, R., Meshkov, A., Stanasiuk, C., G\u00e4rtner, A., Divashuk, M., Sotnikova, E., and Koretskiy, S. (2021). The Desmin (DES) Mutation p.A337P Is Associated with Left-Ventricular Non-Compaction Cardiomyopathy. Genes, 12.","DOI":"10.3390\/genes12010121"},{"key":"ref_50","first-page":"1847","article-title":"Noncompaction cardiomyopathy\u2014A review of eight cases","volume":"29","author":"Toste","year":"2010","journal-title":"Port. J. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1161\/01.CIR.82.2.507","article-title":"Isolated noncompaction of left ventricular myocardium. A study of eight cases","volume":"82","author":"Chin","year":"1990","journal-title":"Circulation"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/heart.86.6.666","article-title":"Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: A step towards classification as a distinct cardiomyopathy","volume":"86","author":"Jenni","year":"2001","journal-title":"Heart"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1573403X16666200716151015","article-title":"Left Ventricular Noncompaction: New Insights into a Poorly Understood Disease","volume":"17","author":"Filho","year":"2021","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4330\/wjc.v14.i1.29","article-title":"Role of genetic testing in cardiomyopathies: A primer for cardiologists","volume":"14","author":"Vogiatzi","year":"2022","journal-title":"World J. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","article-title":"Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline","volume":"24","author":"Hershberger","year":"2018","journal-title":"J. Card. Fail."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1136\/jmg.2005.033886","article-title":"Compound and double mutations in patients with hypertrophic cardiomyopathy: Implications for genetic testing and counselling","volume":"42","author":"Ingles","year":"2005","journal-title":"J. Med. Genet."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/gim.2013.204","article-title":"The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing","volume":"16","author":"Pugh","year":"2014","journal-title":"Genet. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cardfail.2012.01.013","article-title":"Genetic testing for dilated cardiomyopathy in clinical practice","volume":"18","author":"Lakdawala","year":"2012","journal-title":"J. Card. Fail."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jmoldx.2012.09.002","article-title":"Inherited cardiomyopathies: Molecular genetics and clinical genetic testing in the postgenomic era","volume":"15","author":"Teekakirikul","year":"2013","journal-title":"J. Mol. Diagn."},{"key":"ref_60","first-page":"1307","article-title":"European Heart Rhythm Association (EHRA)\/Heart Rhythm Society (HRS)\/Asia Pacific Heart Rhythm Society (APHRS)\/Latin American Heart Rhythm Society (LAHRS) Expert Consensus Statement on the state of genetic testing for cardiac diseases","volume":"24","author":"Wilde","year":"2022","journal-title":"EP Eur."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCULATIONAHA.106.666016","article-title":"Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: The REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial","volume":"116","author":"Colucci","year":"2007","journal-title":"Circulation"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"Yusuf","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1161\/CIRCHEARTFAILURE.108.817346","article-title":"Progress with genetic cardiomyopathies: Screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia\/cardiomyopathy. Circulation","volume":"2","author":"Hershberger","year":"2009","journal-title":"Heart Fail."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/eurheartj\/ehr218","article-title":"ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)","volume":"32","author":"Borghi","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/cvr\/cvu014","article-title":"Pregnancy, cardiomyopathies, and genetics","volume":"101","author":"Pieper","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijcard.2010.05.045","article-title":"Prediction of complications in pregnant women with cardiac diseases referred to a tertiary center","volume":"151","author":"Jastrow","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/hc3001.093437","article-title":"Prospective multicenter study of pregnancy outcomes in women with heart disease","volume":"104","author":"Siu","year":"2001","journal-title":"Circulation"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/S0735-1097(02)02495-6","article-title":"Risk associated with pregnancy in hypertrophic cardiomyopathy","volume":"40","author":"Autore","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_69","first-page":"613","article-title":"Short and long-term outcome of pregnant women with preexisting dilated cardiomypathy: An NTproBNP and echocardiography-guided study","volume":"12","author":"Blatt","year":"2010","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e024960","DOI":"10.1161\/JAHA.121.024960","article-title":"Pregnancy and Progression of Cardiomyopathy in Women with LMNA Genotype-Positive","volume":"11","author":"Castrini","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/eurjhf\/hfr040","article-title":"Systematic review of pregnancy in women with inherited cardiomyopathies","volume":"13","author":"Krul","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/HCO.0b013e3283439797","article-title":"Recent progress in the genetics of cardiomyopathy and its role in the clinical evaluation of patients with cardiomyopathy","volume":"26","author":"Ghosh","year":"2011","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.108.804617","article-title":"Sudden deaths in young competitive athletes: Analysis of 1866 deaths in the United States, 1980\u20132006","volume":"119","author":"Maron","year":"2009","journal-title":"Circulation"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.0000128363.85581.E1","article-title":"Recommendations for physical activity and recreational sports participation for young patients with genetic cardiovascular diseases","volume":"109","author":"Maron","year":"2004","journal-title":"Circulation"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1161\/CIRCULATIONAHA.117.027828","article-title":"Safety of Sports for Athletes with Implantable Cardioverter-Defibrillators: Long-Term Results of a Prospective Multinational Registry","volume":"135","author":"Lampert","year":"2017","journal-title":"Circulation"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ijcard.2017.07.015","article-title":"Vigorous exercise in patients with hypertrophic cardiomyopathy","volume":"250","author":"Dejgaard","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_77","first-page":"e273","article-title":"Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement from the American Heart Association and American College of Cardiology","volume":"132","author":"Maron","year":"2015","journal-title":"Circulation"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/eurheartj\/ehaa605","article-title":"2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease","volume":"42","author":"Pelliccia","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2013.06.033","article-title":"Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"62","author":"James","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_80","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/heartjnl-2012-303418","article-title":"Increased left ventricular trabeculation in highly trained athletes: Do we need more stringent criteria for the diagnosis of left ventricular non-compaction in athletes?","volume":"99","author":"Gati","year":"2013","journal-title":"Heart"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/CIRCULATIONAHA.111.023846","article-title":"Sudden cardiac death caused by coronary heart disease","volume":"125","author":"Myerburg","year":"2012","journal-title":"Circulation"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCULATIONAHA.115.017633","article-title":"Hypertrophic Cardiomyopathy in Children, Adolescents, and Young Adults Associated with Low Cardiovascular Mortality with Contemporary Management Strategies","volume":"133","author":"Maron","year":"2016","journal-title":"Circulation"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","article-title":"A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)","volume":"35","author":"Jichi","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ccep.2017.07.009","article-title":"Sudden Cardiac Death in Genetic Cardiomyopathies","volume":"9","author":"Atteya","year":"2017","journal-title":"Card. Electrophysiol. Clin."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1056\/NEJM199412083312307","article-title":"Idiopathic dilated cardiomyopathy","volume":"331","author":"Dec","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.amjcard.2015.06.022","article-title":"Contemporary Outcome in Patients With Idiopathic Dilated Cardiomyopathy","volume":"116","author":"Broch","year":"2015","journal-title":"Am. J. Cardiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_89","first-page":"1665","article-title":"Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: A pooled analysis","volume":"24","author":"Agbaedeng","year":"2022","journal-title":"EP Eur."},{"key":"ref_90","first-page":"3227","article-title":"Treatment of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: An international task force consensus statement","volume":"36","author":"Corrado","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2009.11.062","article-title":"Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations","volume":"55","author":"Girolami","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_92","first-page":"861","article-title":"Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: Spectrum of mutations and clinical impact in practice","volume":"12","author":"Fressart","year":"2010","journal-title":"EP Eur."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/14\/4706\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:12:43Z","timestamp":1760127163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/14\/4706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,15]]},"references-count":92,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["jcm12144706"],"URL":"https:\/\/doi.org\/10.3390\/jcm12144706","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,15]]}}}